LZI Tramadol Enzyme Immunoassay— 510(k) K201223
Substantially EquivalentLin-Zhi International, Inc.
FDA 510(k) clearance K201223 for LZI Tramadol Enzyme Immunoassay, Substantially Equivalent on 2020-06-04. Applicant: Lin-Zhi International, Inc..
Clearance details
- Applicant
- Lin-Zhi International, Inc.
- Product code
- Code DJG
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Santa Clara, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.